Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Advances in Palliative Medicine
MENU
Shortcuts

open access

Vol 2, No 3 (2003): Polish Palliative Medicine
Leki w medycynie paliatywnej
Published online: 2003-05-29
View PDF (Polish) Download PDF file
Get Citation

Prokinetics in palliative care

Anna Adamczyk
Advances in Palliative Medicine 2003;2(3):199-202.

open access

Vol 2, No 3 (2003): Polish Palliative Medicine
Leki w medycynie paliatywnej
Published online: 2003-05-29

Abstract

Prokinetics accelerate gastric emptying and intestinal transit by interaction with neurohumoral pathways. Currently used prokinetics include: D2 receptor antagonists - domperidone and metoclopramide, 5-HT4 receptor agonists - cisapride and metoclopramide and motilin agonist - erythromycin. Indications for prokinetics in palliative care are nausea and vomiting caused by gastrostasis, gastro-oesophageal reflux, functional bowel obstruction, constipation, gastroparesis and irritable bowel syndrome.

Abstract

Prokinetics accelerate gastric emptying and intestinal transit by interaction with neurohumoral pathways. Currently used prokinetics include: D2 receptor antagonists - domperidone and metoclopramide, 5-HT4 receptor agonists - cisapride and metoclopramide and motilin agonist - erythromycin. Indications for prokinetics in palliative care are nausea and vomiting caused by gastrostasis, gastro-oesophageal reflux, functional bowel obstruction, constipation, gastroparesis and irritable bowel syndrome.

Full Text:

View PDF (Polish) Download PDF file
Get Citation

Keywords

prokinetics; receptor D2 antagonist; receptor 5-HT4 agonist; motilin

About this article
Title

Prokinetics in palliative care

Journal

Advances in Palliative Medicine

Issue

Vol 2, No 3 (2003): Polish Palliative Medicine

Pages

199-202

Published online

2003-05-29

Page views

519

Article views/downloads

6223

Bibliographic record

Advances in Palliative Medicine 2003;2(3):199-202.

Keywords

prokinetics
receptor D2 antagonist
receptor 5-HT4 agonist
motilin

Authors

Anna Adamczyk

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl